Literature DB >> 16870527

Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration.

Alasdair Reid1, Fabio Scano, Haileyesus Getahun, Brian Williams, Christopher Dye, Paul Nunn, Kevin M De Cock, Catherine Hankins, Bess Miller, Kenneth G Castro, Mario C Raviglione.   

Abstract

Tuberculosis is the oldest of the world's current pandemics and causes 8.9 million new cases and 1.7 million deaths annually. The disease is among the most common causes of morbidity and mortality in people living with HIV. However, tuberculosis is more than just part of the global HIV problem; well-resourced tuberculosis programmes are an important part of the solution to scaling-up towards universal access to comprehensive HIV prevention, diagnosis, care, and support. This article reviews the impact of the interactions between tuberculosis and HIV in resource-limited settings; outlines the recommended programmatic and clinical responses to the dual epidemics, highlighting the role of tuberculosis/HIV collaboration in increasing access to prevention, diagnostic, and treatment services; and reviews progress in the global response to the epidemic of HIV-related tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16870527     DOI: 10.1016/S1473-3099(06)70549-7

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  39 in total

1.  Improved detection of latent Mycobacterium tuberculosis infection in HIV-1 seropositive individuals using cultured cellular assays.

Authors:  Suzanne Campion; Myron S Cohen; Andrew J McMichael; Shannon Galvin; Nilu Goonetilleke
Journal:  Eur J Immunol       Date:  2010-12-01       Impact factor: 5.532

2.  The new Stop TB Strategy and the Global Plan to Stop TB, 2006-2015.

Authors:  Mario C Raviglione
Journal:  Bull World Health Organ       Date:  2007-05       Impact factor: 9.408

3.  Evaluation of TBc identification immunochromatographic assay for rapid identification of Mycobacterium tuberculosis complex in samples from broth cultures.

Authors:  Halima M Said; Nazir Ismail; Ayman Osman; Chrisna Velsman; A A Hoosen
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

4.  Exploring the relative costs of contact tracing for increasing HIV case finding in sub-Saharan countries.

Authors:  Benjamin Armbruster; Stéphane Helleringer; Linda Kalilani-Phiri; James Mkandawire; Hans-Peter Kohler
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

Review 5.  Epidemiology and challenges to the elimination of global tuberculosis.

Authors:  Mandeep S Jassal; William R Bishai
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

6.  Tuberculosis in complex emergencies.

Authors:  Rudi Coninx
Journal:  Bull World Health Organ       Date:  2007-08       Impact factor: 9.408

7.  Multidrug resistance to Mycobacterium tuberculosis in a tertiary hospital.

Authors:  Aderemi Oludiran Kehinde; Felix Ariebuwa Obaseki; Oluponle Christiana Ishola; Kolo Doko Ibrahim
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

8.  Scaling up integration: development and results of a participatory assessment of HIV/TB services, South Africa.

Authors:  Vera Scott; Mickey Chopra; Virginia Azevedo; Judy Caldwell; Pren Naidoo; Brenda Smuts
Journal:  Health Res Policy Syst       Date:  2010-07-13

9.  Effects of tuberculosis on the kinetics of CD4(+) T cell count among HIV-infected patients who initiated antiretroviral therapy early after tuberculosis treatment.

Authors:  Nam Su Ku; Jin Ok Oh; So Youn Shin; Sun Bean Kim; Hye-won Kim; Su Jin Jeong; Sang Hoon Han; Young Goo Song; June Myung Kim; Jun Yong Choi
Journal:  AIDS Res Hum Retroviruses       Date:  2012-09-11       Impact factor: 2.205

10.  Clinical presentation, demographics and outcome of tuberculosis (TB) in a low incidence area: a 4-year study in Geneva, Switzerland.

Authors:  Omar Kherad; François R Herrmann; Jean-Pierre Zellweger; Thierry Rochat; Jean-Paul Janssens
Journal:  BMC Infect Dis       Date:  2009-12-31       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.